Health | Costco Costco Jumps on the Weight-Loss Bandwagon Warehouse retailer now offers 3-month program that could include meds like Ozempic By Jenn Gidman Posted Apr 3, 2024 7:45 AM CDT Copied A Costco warehouse is seen Friday in Cranberry Township, Pennsylvania. (AP Photo/Gene J. Puskar) Those long lines for $1.50 hot dog meals may be shrinking, but Costco could soon see a queue starting for its newest service: weight-loss management. CBS News reports that the warehouse retailer has teamed up with health care marketplace Sesame to offer Costco members access to a program that could include weight-loss drugs like Ozempic. Details: Members are now able to register for the service, which runs $179 for three months, not counting the cost of any medications that may be prescribed. The program includes video consultations with a weight-loss specialist, unlimited messaging with a health care provider for support, and access to weight-loss meds, if a patient is eligible, per CNN. Sesame says it can prescribe injectable semaglutides like Ozempic and Wegovy or oral medications. Accessibility: CNN notes that while more affluent patients have been accessing weight-loss drugs for a while, Costco hopes its newest offering will open the door to even more people. "Obesity is prevalent across every socioeconomic status in America. There are a lot of people who have this interest and who have this need and we saw that in the data," Sesame co-founder Michael Botta tells CNN. Drug costs: Still, meds available through this renewable program are in addition to the $179 three-month fee, and it doesn't look cheap. Sesame notes on its site that GLP-1 drugs like this can cost between $950 and $1,600 per month without insurance. Partnership: Costco and Sesame also teamed up last year to offer $29 visits with a primary care doctor. This latest initiative came about due to customer inquiries. "The No. 1 search term of Costco members seeking primary care on Sesame was around weight-loss," Sesame CEO David Goldhill tells USA Today. The future: JPMorgan researchers predict that nearly 10% of the US population, or about 30 million people, may be taking GLP-1 drugs by 2030, per CNN. Read These Next Rubio says the fate of Iran's conversion facility is what matters. Some of the most explosive Diddy allegations are dropped. Fan who taunted Ketel Marte's mom has been banned by MLB. NJ lifeguard survives after being impaled by an umbrella. Report an error